Improvement of Functioning and Health With Ixekizumab in the Treatment of Active Nonradiographic Axial Spondyloarthritis in a 52-Week, Randomized, Controlled Trial

J.A. Walsh; M.N. Magrey; X. Baraliakos; K. Inui; M.Y. Weng; E. Lubrano; D. van der Heijde; A. Boonen; L.S. Gensler; V. Strand; J. Braun; T. Hunter; X.Q. Li; B.J. Zhu; L. Leon; D.M.S. Calderon; U. Kiltz

doi:10.1002/acr.24482

Improvement of Functioning and Health With Ixekizumab in the Treatment of Active Nonradiographic Axial Spondyloarthritis in a 52-Week, Randomized, Controlled Trial

J.A. Walsh, M.N. Magrey, X. Baraliakos, K. Inui, M.Y. Weng, E. Lubrano, D. van der Heijde, A. Boonen, L.S. Gensler, V. Strand, J. Braun, T. Hunter, X.Q. Li, B.J. Zhu, L. Leon, D.M.S. Calderon, U. Kiltz^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

5 Citations (Web of Science)

Original language	English
Pages (from-to)	451-460
Number of pages	10
Journal	Arthritis Care and Research
Volume	74
Issue number	3
Early online date	26 Jan 2022
DOIs	https://doi.org/10.1002/acr.24482
Publication status	Published - Mar 2022

Keywords

PATIENT-REPORTED OUTCOMES
ANKYLOSING-SPONDYLITIS
MONOCLONAL-ANTIBODY
CERTOLIZUMAB PEGOL
DOUBLE-BLIND
CRITERIA
ETANERCEPT
EFFICACY

Access to Document

10.1002/acr.24482Licence: Other

Cite this

Walsh, J. A., Magrey, M. N., Baraliakos, X., Inui, K., Weng, M. Y., Lubrano, E., van der Heijde, D., Boonen, A., Gensler, L. S., Strand, V., Braun, J., Hunter, T., Li, X. Q., Zhu, B. J., Leon, L., Calderon, D. M. S., & Kiltz, U. (2022). Improvement of Functioning and Health With Ixekizumab in the Treatment of Active Nonradiographic Axial Spondyloarthritis in a 52-Week, Randomized, Controlled Trial. Arthritis Care and Research, 74(3), 451-460. https://doi.org/10.1002/acr.24482

Walsh, J.A. ; Magrey, M.N. ; Baraliakos, X. ; Inui, K. ; Weng, M.Y. ; Lubrano, E. ; van der Heijde, D. ; Boonen, A. ; Gensler, L.S. ; Strand, V. ; Braun, J. ; Hunter, T. ; Li, X.Q. ; Zhu, B.J. ; Leon, L. ; Calderon, D.M.S. ; Kiltz, U. / Improvement of Functioning and Health With Ixekizumab in the Treatment of Active Nonradiographic Axial Spondyloarthritis in a 52-Week, Randomized, Controlled Trial. In: Arthritis Care and Research. 2022 ; Vol. 74, No. 3. pp. 451-460.

@article{acac3b8bc6724fc0ad8563dbb586c73e,

title = "Improvement of Functioning and Health With Ixekizumab in the Treatment of Active Nonradiographic Axial Spondyloarthritis in a 52-Week, Randomized, Controlled Trial",

keywords = "PATIENT-REPORTED OUTCOMES, ANKYLOSING-SPONDYLITIS, MONOCLONAL-ANTIBODY, CERTOLIZUMAB PEGOL, DOUBLE-BLIND, CRITERIA, ETANERCEPT, EFFICACY",

author = "J.A. Walsh and M.N. Magrey and X. Baraliakos and K. Inui and M.Y. Weng and E. Lubrano and {van der Heijde}, D. and A. Boonen and L.S. Gensler and V. Strand and J. Braun and T. Hunter and X.Q. Li and B.J. Zhu and L. Leon and D.M.S. Calderon and U. Kiltz",

year = "2022",

month = mar,

doi = "10.1002/acr.24482",

language = "English",

volume = "74",

pages = "451--460",

journal = "Arthritis Care and Research",

issn = "2151-4658",

publisher = "Wiley",

number = "3",

}

Walsh, JA, Magrey, MN, Baraliakos, X, Inui, K, Weng, MY, Lubrano, E, van der Heijde, D, Boonen, A, Gensler, LS, Strand, V, Braun, J, Hunter, T, Li, XQ, Zhu, BJ, Leon, L, Calderon, DMS & Kiltz, U 2022, 'Improvement of Functioning and Health With Ixekizumab in the Treatment of Active Nonradiographic Axial Spondyloarthritis in a 52-Week, Randomized, Controlled Trial', Arthritis Care and Research, vol. 74, no. 3, pp. 451-460. https://doi.org/10.1002/acr.24482

Improvement of Functioning and Health With Ixekizumab in the Treatment of Active Nonradiographic Axial Spondyloarthritis in a 52-Week, Randomized, Controlled Trial. / Walsh, J.A.; Magrey, M.N.; Baraliakos, X.; Inui, K.; Weng, M.Y.; Lubrano, E.; van der Heijde, D.; Boonen, A.; Gensler, L.S.; Strand, V.; Braun, J.; Hunter, T.; Li, X.Q.; Zhu, B.J.; Leon, L.; Calderon, D.M.S.; Kiltz, U.

In: Arthritis Care and Research, Vol. 74, No. 3, 03.2022, p. 451-460.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Improvement of Functioning and Health With Ixekizumab in the Treatment of Active Nonradiographic Axial Spondyloarthritis in a 52-Week, Randomized, Controlled Trial

AU - Walsh, J.A.

AU - Magrey, M.N.

AU - Baraliakos, X.

AU - Inui, K.

AU - Weng, M.Y.

AU - Lubrano, E.

AU - van der Heijde, D.

AU - Boonen, A.

AU - Gensler, L.S.

AU - Strand, V.

AU - Braun, J.

AU - Hunter, T.

AU - Li, X.Q.

AU - Zhu, B.J.

AU - Leon, L.

AU - Calderon, D.M.S.

AU - Kiltz, U.

PY - 2022/3

Y1 - 2022/3

KW - PATIENT-REPORTED OUTCOMES

KW - ANKYLOSING-SPONDYLITIS

KW - MONOCLONAL-ANTIBODY

KW - CERTOLIZUMAB PEGOL

KW - DOUBLE-BLIND

KW - CRITERIA

KW - ETANERCEPT

KW - EFFICACY

U2 - 10.1002/acr.24482

DO - 10.1002/acr.24482

M3 - Article

C2 - 33044756

VL - 74

SP - 451

EP - 460

JO - Arthritis Care and Research

JF - Arthritis Care and Research

SN - 2151-4658

IS - 3

ER -